In Liquidia Techs., Inc. v. United Therapeutics Corp.,[1] the Patent Trial and Appeal Board ("the PTAB") held all challenged claims of U.S. Patent No. 10,716,793 ("the '793 patent") unpatentable under 35 U.S.C. § 103.
As the global economy faces the third year of the pandemic, manufacturers are no longer focused on figuring out when things will return to “normal.” Instead, they are applying lessons.
An Increase of Ethics, Sustainability, and Safety Claims: Green washing-details emerge about purportedly unethical or unsustainable practices within these manufacturers’ supply chains. False advertising claims are also on the rise where companies fail to disclose health risks
Greenwashing And False Advertising Class Action Suits natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Defending class action claims alleging false product labeling on the presence of per- and polyfluoroalkyl substances PFAS. plaintiffs assert a premium price theory claims that he or she would not have purchased the item, or would have paid less, had PFAS been disclosed.